Georgetown-Lombardi Comprehensive Cancer Ctr

Washington D.C., District of Columbia 20057

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Studies at this site

• Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation — Paused